We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 123

The Court of Appeal’s recent decision on the parallel import of pharmaceutical products
  • Bird & Bird
  • United Kingdom
  • February 28 2008

Following two preliminary references to the European Court of Justice (“ECJ”), on 21 February 2008, the Court of Appeal handed down the latest decision in the long running pharmaceutical parallel import case of Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited (2008 EWCA Civ 83


Protection of dosage regiment for medicaments under the new European Patent Convention 2000
  • Bird & Bird
  • European Union
  • July 16 2008

The discussion before the European Patent Office on patentability of second medical use claims has now entered another round


Edwards Lifesciences AG v Cook Biotech Incorporated
  • Bird & Bird
  • United Kingdom
  • July 17 2009

Mr Justice Kitchin handed down a decision only four weeks after the hearing, finding Cook’s patent invalid and not infringed by Edwards’ SAPIEN heart valve


New regulatory requirements in the pharmaceutical sector
  • Bird & Bird
  • European Union
  • October 30 2008

Regulation (EC) No 19012006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use (hereinafter, “the Paediatric Regulation”) is intended to tackle the problems resulting from the absence of suitably adapted medicinal products for the paediatric population (including inadequate dosage information, non-availability to the paediatric population of therapeutic advances, suitable formulations and routes of administration as well as use of magistral or officinal formulations to treat the paediatric population


The Wellcome Foundation Ltd v Paranova Pharmazeutika Handels GmbH
  • Bird & Bird
  • Austria
  • March 11 2009

Following a reference from the Austrian Supreme Court, the ECJ ruled on two questions relating to the conditions applicable to repackaging of pharmaceutical products in a parallel imports case


Patenting stem cells
  • Bird & Bird
  • Singapore
  • March 11 2009

The life sciences initiative in Singapore began in 2000 when it was identified as the fourth pillar of Singapore’s economy


Paedriatric SPC extension: zero or negative term SPCs
  • Bird & Bird
  • European Union, United Kingdom
  • March 11 2009

Zero or negative term SPCs give rise to a unique disunity amongst the granting authorities in the European Member States


Corevalve Inc. v. Edwards Lifesciences AG & Edwards Lifesciences PVT, Inc
  • Bird & Bird
  • United Kingdom
  • March 11 2009

Edwards Lifesciences, the world leader in replacement heart valves, succeeded in upholding the validity of their patent for a transcatheter valve


UK Patents Court judgment in Dr Reddy’s Laboratories v Eli Lilly
  • Bird & Bird
  • United Kingdom
  • December 31 2008

In a judgment handed down in October of this year, the Patents Court (Mr Justice Floyd) upheld EP (UK) 0,454,436 (the “Patent”) which is owned by Eli Lilly and which protects the schizophrenia drug olanzapine


Court of Appeal decides “settled” EPO case law trumps UK precedent on Swiss-type claim to a new dosage regime
  • Bird & Bird
  • United Kingdom
  • July 16 2008

The Court of Appeal has decided in the case of Actavis UK Ltd v Merck & Co Inc 2008 EWCA Civ 444, that a Swiss-type claim can be patentable where the novelty is only conferred by a new dosage regime or form of administration of a substance